HIA
CRL icon

HFM Investment Advisors’s Charles River Laboratories CRL Stock Holding History

HFM Investment Advisors’s Portfolio CRL Stock Details CRL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.81K Buy
8
+5
+167% +$890 ﹤0.01% 494
2026
Q1 		$518 Hold
3
– – ﹤0.01% 664
2025
Q4 		$599 Hold
3
– – ﹤0.01% 648
2025
Q3 		$469 Buy
3
+2
+200% +$318 ﹤0.01% 685
2025
Q2 		$152 Hold
1
– – ﹤0.01% 1066
2025
Q1 		$151 Buy
+1
New +$168 ﹤0.01% 733

Other funds holding CRL

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Harris Associates
Harris Associates Chicago, Illinois $75.4B AUM 14.46% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Allspring Global Investments
Allspring Global Investments Charlotte, North Carolina $65.2B AUM 39.42% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
AI
Ariel Investments Chicago, Illinois $10B AUM 42.59% 1-Year Est. Return

HFM Investment Advisors's CRL Position: Q2 2026 in Review

HFM Investment Advisors increased its Charles River Laboratories (CRL) stake by 167% in Q2 2026, buying an estimated $890 and bringing the position to 8 shares worth $1.81K. The position accounts for ﹤0.01% of the portfolio, ranked #494.

HFM Investment Advisors first reported a position in CRL in Q1 2025 and has held it in 6 quarters since. 570 funds tracked by Wall St. Rank hold CRL as of Q2 2026.

  • HFM Investment Advisors held 8 shares of Charles River Laboratories worth $1.81K as of Q2 2026.
  • HFM Investment Advisors bought 5 Charles River Laboratories shares in Q2 2026, an estimated $890.
  • Charles River Laboratories made up ﹤0.01% of HFM Investment Advisors's portfolio in Q2 2026, its #494 holding.
  • HFM Investment Advisors first reported a position in Charles River Laboratories in Q1 2025 and has held it in 6 quarters since.
  • 570 funds tracked by Wall St. Rank held Charles River Laboratories as of Q2 2026.

Based on HFM Investment Advisors's 13F filing for Q2 2026, filed 4 Aug 2026.